Julia Hambach
-
- Monoclonal and Polyclonal Antibodies Research 8
- Immunology top 10%
- T-cell and B-cell Immunology 2
- Physiology top 10%
- Adenosine and Purinergic Signaling 2
-
- Peptidase Inhibition and Analysis 3
-
- Glycosylation and Glycoproteins Research 6
-
- Multiple Myeloma Research and Treatments 3
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
In The Last Decade
Julia Hambach
13 papers receiving 605 citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Radiology, Nuclear Medicine and Imaging 345
- Immunology 221
- Physiology 41
- Oncology 199
- Molecular Biology 281
Countries citing papers authored by Julia Hambach
This map shows the geographic impact of Julia Hambach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Hambach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Hambach more than expected).
Fields of papers citing papers by Julia Hambach
This network shows the impact of papers produced by Julia Hambach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Hambach. The network helps show where Julia Hambach may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julia Hambach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 27 | |
| 3 | 2022 | 17 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 14 | |
| 11 | 2020 | 59 | |
| 12 | 2018 | 42 | |
| 13 | Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeuticsbreakdown → | 2017 | 413 |
About Julia Hambach
Julia Hambach is a scholar working on Physiology, Hematology, Radiology, Nuclear Medicine and Imaging, Immunology and Urology, having authored 13 papers that have together received 611 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (6 papers), Peptidase Inhibition and Analysis (3 papers), Multiple Myeloma Research and Treatments (3 papers), Adenosine and Purinergic Signaling (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (345 citations), Immunology (221 citations), Physiology (41 citations), Oncology (199 citations) and Molecular Biology (281 citations). Julia Hambach has collaborated with scholars based in Germany and Belgium. Frequent co-authors include Friedrich Koch‐Nolte, Peter Bannas, Friedrich Haag, Gerhard Adam, Boris Fehse, Kristoffer Riecken, Stephan Menzel, Timon Hansen, Gunter Schuch and Nicolaus Kröger. Their work appears in journals such as Frontiers in Immunology, Cancers, BMC Urology, Cells and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.